Epilepsy is associated with reduced REM sleep in children, with the effect strongest under age 6 and amplified by antiseizure medications
In a propensity score-matched cross-sectional study of 560 children with epilepsy and 560 non-epilepsy clinical comparators, children with epilepsy had significantly reduced REM sleep (median 18.2% vs 20.9%, g=-0.32, FDR p<0.001). The REM deficit was amplified by antiseizure medication use (15.8% vs 19.8%, g=-0.48, p<0.001) and followed a developmental gradient, being strongest in children under 6 years (g=-0.38) and not detected in those over 12 years (g=-0.07, p=0.953).
This article is automatically generated from the structured evidence profile behind the claim above. Scores reflect the quality and quantity of available research, not clinical advice.
Epilepsy is associated with reduced REM sleep in children, with the effect strongest under age 6 and amplified by antiseizure medications The current body of evidence comprises 1 study. EvidenceHub rates the overall confidence at 34/100 (low).
The Claim
Epilepsy is associated with reduced REM sleep in children, with the effect strongest under age 6 and amplified by antiseizure medications
This conclusion is most relevant to: Children aged ≤18 years referred for polysomnography, including 560 with epilepsy and 560 matched non-epilepsy clinical comparators.
What the Research Shows
The conclusion draws on 1 linked study. Highlights from the cited literature:
- ▸Rapid eye movement sleep reduction in pediatric epilepsy: A propensity score-matched study. (Epilepsia, 2026) —
How It Works
The proposed biological pathway:
- ▸Epilepsy or antiseizure medications disrupt REM sleep regulation
- ▸The effect is more pronounced in younger children, suggesting developmental vulnerability
- ▸ASM use further suppresses REM sleep
- ▸Result: Reduced REM sleep percentage and prolonged REM latency in pediatric epilepsy
Who Might Benefit
Evidence fit by population:
- ▸Children aged ≤18 years referred for polysomnography, including 560 with epilepsy and 560 matched non-epilepsy clinical comparators
Recommended Dose
N/A
Limitations & Caveats
Important context when interpreting this evidence:
- ▸Cross-sectional design prevents causal inference
- ▸Independent contribution of epilepsy itself remains uncertain due to confounding by indication and medication effects
- ▸Clinical cohort referred for PSG may not represent all children with epilepsy
Frequently Asked Questions
What is the main sleep finding in children with epilepsy?▼
Children with epilepsy have reduced REM sleep (median 18.2% vs 20.9% in non-epilepsy comparators) and lower sleep efficiency, shorter total sleep time, and prolonged REM latency.
Does antiseizure medication affect REM sleep?▼
Yes, ASM use amplified the REM deficit, with REM sleep at 15.8% in ASM users vs 19.8% in non-users (g=-0.48).
At what age is the REM sleep reduction most pronounced?▼
The effect was strongest in children under 6 years (g=-0.38), intermediate at 6-12 years (g=-0.31), and not detected in those over 12 years (g=-0.07).
What is the sample size of this study?▼
The study included 560 PSG studies from children with epilepsy and 560 matched non-epilepsy comparators after propensity score matching.
References
- 1.Juginović A, Rodman L. “Rapid eye movement sleep reduction in pediatric epilepsy: A propensity score-matched study..” Epilepsia, 2026. PMID: 42615232 DOI: 10.1002/epi.70433